Patents Assigned to Genzyem Corporation
  • Publication number: 20130324465
    Abstract: The invention provides compositions and methods for treating a disease or disorder associated with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.
    Type: Application
    Filed: August 5, 2011
    Publication date: December 5, 2013
    Applicant: Genzyem Corporation
    Inventors: James Stefano, Clark Pan, Huawei Qiu, Michael O'Callaghan, Gloria Matthews